Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia.
暂无分享，去创建一个
M. Dyer | T. Kipps | S. Stilgenbauer | T. Robak | W. Wierda | A. Osterborg | M. Trněný | R. Furman | S. Padmanabhan | G. Chan | J. Mayer | P. Hillmen | N. Losic | A. Hellmann | C. Russell | T. Kozák | Cathy D. Williams | M. Piotrowska | Randy L. Davis | J. Wilms